Rosenholm JM - Search Results

1

Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.

Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M. Rosenholm JM, et al. Nanomedicine (Lond). 2012 Jan;7(1):111-20. doi: 10.2217/nnm.11.166. Nanomedicine (Lond). 2012. PMID: 22191780 Review.

2

Amino-functionalization of large-pore mesoscopically ordered silica by a one-step hyperbranching polymerization of a surface-grown polyethyleneimine.

Rosenholm JM, Penninkangas A, Lindén M. Rosenholm JM, et al. Chem Commun (Camb). 2006 Oct 1;(37):3909-11. doi: 10.1039/b607886a. Epub 2006 Aug 4. Chem Commun (Camb). 2006. PMID: 17268667

3

On the nature of the Brønsted acidic groups on native and functionalized mesoporous siliceous SBA-15 as studied by benzylamine adsorption from solution.

Rosenholm JM, Czuryszkiewicz T, Kleitz F, Rosenholm JB, Lindén M. Rosenholm JM, et al. Among authors: rosenholm jb. Langmuir. 2007 Apr 10;23(8):4315-23. doi: 10.1021/la062450w. Epub 2007 Mar 10. Langmuir. 2007. PMID: 17348693

4

Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications.

Rosenholm JM, Lindén M. Rosenholm JM, et al. J Control Release. 2008 Jun 4;128(2):157-64. doi: 10.1016/j.jconrel.2008.02.013. Epub 2008 Mar 6. J Control Release. 2008. PMID: 18439699

5

Targeting of porous hybrid silica nanoparticles to cancer cells.

Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. ACS Nano. 2009 Jan 27;3(1):197-206. doi: 10.1021/nn800781r. ACS Nano. 2009. PMID: 19206267

6

Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.

Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Nano Lett. 2009 Sep;9(9):3308-11. doi: 10.1021/nl901589y. Nano Lett. 2009. PMID: 19736973

7

Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.

Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Small. 2010 Jun 6;6(11):1234-41. doi: 10.1002/smll.200902355. Small. 2010. PMID: 20486218

8

Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.

Rosenholm JM, Sahlgren C, Lindén M. Rosenholm JM, et al. Nanoscale. 2010 Oct;2(10):1870-83. doi: 10.1039/c0nr00156b. Epub 2010 Aug 23. Nanoscale. 2010. PMID: 20730166 Review.

9

Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.

Rosenholm JM, Sahlgren C, Lindén M. Rosenholm JM, et al. Curr Drug Targets. 2011 Jul 1;12(8):1166-86. doi: 10.2174/138945011795906624. Curr Drug Targets. 2011. PMID: 21443474 Review.

10

Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.

Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Lindén M, Sahlgren C. Mamaeva V, et al. Among authors: rosenholm jm. Mol Ther. 2011 Aug;19(8):1538-46. doi: 10.1038/mt.2011.105. Epub 2011 May 31. Mol Ther. 2011. PMID: 21629222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters